1,933
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon &
Pages 1365-1379 | Published online: 24 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jonathan Zaslavsky, Pauric Bannigan & Christine Allen. (2023) Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence. Expert Opinion on Drug Delivery 20:2, pages 241-257.
Read now

Articles from other publishers (13)

Long Yuan, Qiran Chen, Jim E. Riviere & Zhoumeng Lin. (2023) Pharmacokinetics and tumor delivery of nanoparticles. Journal of Drug Delivery Science and Technology 83, pages 104404.
Crossref
Anita Bakrania, Narottam Joshi, Xun Zhao, Gang Zheng & Mamatha Bhat. (2023) Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases. Pharmacological Research 189, pages 106706.
Crossref
Atchara Chinnakorn, Wiwat Nuansing, Mahdi Bodaghi, Bernard Rolfe & Ali Zolfagharian. (2023) Recent progress of 4D printing in cancer therapeutics studies. SLAS Technology.
Crossref
Wei-Chun Chou & Zhoumeng Lin. (2023) Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling. Toxicological Sciences 191:1, pages 1-14.
Crossref
Warren C. W. Chan. (2023) Principles of Nanoparticle Delivery to Solid Tumors. BME Frontiers 4.
Crossref
Zhoumeng Lin, Santosh Aryal, Yi-Hsien Cheng & Andre J. Gesquiere. (2022) Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling. ACS Nano 16:12, pages 19722-19754.
Crossref
Wei-Chun Chou, Yi-Hsien Cheng, Jim E. Riviere, Nancy A. Monteiro-Riviere, Wolfgang G. Kreyling & Zhoumeng Lin. (2022) Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats. Particle and Fibre Toxicology 19:1.
Crossref
Qiran Chen, Jim E. Riviere & Zhoumeng Lin. (2022) Toxicokinetics, dose–response, and risk assessment of nanomaterials: Methodology, challenges, and future perspectives. WIREs Nanomedicine and Nanobiotechnology 14:6.
Crossref
Elena O. Kutumova, Ilya R. Akberdin, Ilya N. Kiselev, Ruslan N. Sharipov, Vera S. Egorova, Anastasiia O. Syrocheva, Alessandro Parodi, Andrey A. ZamyatninJr.Jr. & Fedor A. Kolpakov. (2022) Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools. International Journal of Molecular Sciences 23:20, pages 12560.
Crossref
Ying Chen, Jiawen He & Meihua Wang. (2022) A hybrid of long short-term memory neural network and autoregressive integrated moving average model in forecasting HIV incidence and morality of post-neonatal population in East Asia: global burden of diseases 2000–2019. BMC Public Health 22:1.
Crossref
Tingting Yang, Jingming Zhai, Dong Hu, Ruyue Yang, Guidan Wang, Yuanpei Li & Gaofeng Liang. (2022) “Targeting Design” of Nanoparticles in Tumor Therapy. Pharmaceutics 14:9, pages 1919.
Crossref
Zhoumeng Lin & Wei-Chun Chou. (2022) Machine Learning and Artificial Intelligence in Toxicological Sciences. Toxicological Sciences 189:1, pages 7-19.
Crossref
Jiunn-Diann Lin, Dee Pei, Fang-Yu Chen, Chung-Ze Wu, Chieh-Hua Lu, Li-Ying Huang, Chun-Heng Kuo, Shi-Wen Kuo & Yen-Lin Chen. (2022) Comparison between Machine Learning and Multiple Linear Regression to Identify Abnormal Thallium Myocardial Perfusion Scan in Chinese Type 2 Diabetes. Diagnostics 12:7, pages 1619.
Crossref